New pyrrolopyrimidin-6-yl benzenesulfonamides:: Potent A2B adenosine receptor antagonists

被引:18
|
作者
Esteve, Cristina
Nueda, Arsenio
Diaz, Jose Luis
Beleta, Jorge
Cardenas, Alvaro
Lozoya, Estrella
Cadavid, Maria Isabel
Loza, Maria Isabel
Ryder, Hamish
Vidal, Bernat
机构
[1] Almirall, Dept Med Chem, E-08960 Barcelona, Spain
[2] Almirall, Dept Biol, E-08980 Barcelona, Spain
[3] Almirall, Dept Biol Struct, E-08980 Barcelona, Spain
[4] Univ Santiago de Compostela, Dept Farmacol, E-15782 Santiago De Compostela, Spain
关键词
A(2B) adenosine receptor antagonists; asthma; pyrrolopyrimidine; sulfonamides;
D O I
10.1016/j.bmcl.2006.04.074
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of 4-(1,3-dialkyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)benzenesulfonamides has been identified as potent AZB adenosine receptor antagonists. The products have been evaluated for their binding affinities for the human A(2B), A(1) and A(3) adenosine receptors. 6-(4-{[4-(4-Bromobenzyl)piperazin-1-yl]sulfonyl}phenyl)-1,3-dimethyl-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione (16) showed a high affinity for the AZB adenosine receptor (IC50 = 1 nM) and selectivity (A(1): 183x; A(30): 12660x). Synthesis and SAR of this novel class of compounds showing improved absorption properties is presented herein. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3642 / 3645
页数:4
相关论文
共 50 条
  • [1] A structural study of new potent and selective antagonists to the A2B adenosine receptor
    Ferretti, V
    Pretto, L
    Tabrizi, MA
    Bertolasi, V
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2005, 61 : 569 - 576
  • [2] Discovery of new antagonists of the adenosine A2B receptor.
    Webb, TR
    Lvovskiy, D
    Melman, N
    Ji, X
    Linden, J
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U6 - U6
  • [3] Prodrugs of A2B adenosine receptor antagonists
    Kalla, Rao
    Elzein, Elfatih
    Koltun, Dmitry
    Li, Xiaofen
    Perry, Thao
    Parkhill, Eric
    Zeng, Dewan
    Fong, Irving
    Leung, Kwan
    Zablocki, Jeff
    PURINERGIC SIGNALLING, 2008, 4 : S21 - S22
  • [4] Irreversible Antagonists for the Adenosine A2B Receptor
    Temirak, Ahmed
    Schlegel, Jonathan G.
    Voss, Jan H.
    Vaassen, Victoria J.
    Vielmuth, Christin
    Claff, Tobias
    Mueller, Christa E.
    MOLECULES, 2022, 27 (12):
  • [5] Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists
    Prieto-Diaz, Ruben
    Gonzalez-Gomez, Manuel
    Fojo-Carballo, Hugo
    Azuaje, Jhonny
    El Maatougui, Abdelaziz
    Majellaro, Maria
    Loza, Maria, I
    Brea, Jose
    Fernandez-Duenas, Victor
    Paleo, M. Rita
    Diaz-Holguin, Alejandro
    Garcia-Pinel, Beatriz
    Mallo-Abreu, Ana
    Estevez, Juan C.
    Andujar-Arias, Antonio
    Garcia-Mera, Xerardo
    Gomez-Tourino, Iria
    Ciruela, Francisco
    Salas, Cristian O.
    Gutierrez-de-Teran, Hugo
    Sotelo, Eddy
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (01) : 890 - 912
  • [6] Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor
    Bedford, Simon T.
    Benwell, Karen R.
    Brooks, Teresa
    Chen, Ijen
    Comer, Mike
    Dugdale, Sarah
    Haymes, Tim
    Jordan, Allan M.
    Kennett, Guy A.
    Knight, Anthony R.
    Klenke, Burkhard
    LeStrat, Loic
    Merrett, Angela
    Misra, Anil
    Lightowler, Sean
    Padfield, Anthony
    Poullennec, Karine
    Reece, Mark
    Simmonite, Heather
    Wong, Melanie
    Yule, Ian A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (20) : 5945 - 5949
  • [7] Selective and potent antagonists for adenosine A2B receptors.
    Kim, YC
    Ji, XD
    Linden, J
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U960 - U960
  • [8] Clinical targets of A2B adenosine receptor antagonists
    Linden, J
    Figler, RA
    Jacobson, KA
    Wang, GQ
    LaNoue, KF
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 556 - 556
  • [9] A2B adenosine receptor antagonists and their potential indications
    Zablocki, Jeff
    Elzein, Elfatih
    Kalla, Rao
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (10) : 1347 - 1357
  • [10] A2B Adenosine Receptor Antagonists with Picomolar Potency
    Jiang, Jie
    Seel, Catharina Julia
    Temirak, Ahmed
    Namasivayam, Vigneshwaran
    Arridu, Antonella
    Schabikowski, Jakub
    Baqi, Younis
    Hinz, Sonja
    Hockemeyer, Joerg
    Mueller, Christa E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (08) : 4032 - 4055